Free company check · Companies House, live

ARTIOS PHARMA LIMITED

active
Company number 09931309
Incorporated
29 Dec 2015
Age
10 years
Company type
Private limited
Registered in
Cambridge
Active directors
7
Sector
Scientific R&D · SIC 72110
Accounts due
30 Sept 2026
Confirmation due
11 Jan 2027
Registered office
Babraham Hall, Cambridge, CB22 3AT
The full check · £9 one-off

This page is the public half. The full check adds sanctions lists (OFSI, OFAC, UN), the FCA register, Gazette and court records, disqualifications, each director's other companies and an adverse-media sweep, read into a plain-English verdict. No account; emailed in minutes.

Tero is reading the filings: share allotments, the shareholder list, the latest accounts, the disqualified-directors register…
Directors
Michael AndrioleFind on LinkedIn ↗
director · since 11 Aug 2025
American · born Sep 1972
director · since 26 Jul 2021
Canadian,British · born Sep 1973
director · since 18 Sept 2024
American · born Dec 1959
Rene Robert KuijtenFind on LinkedIn ↗
director · since 9 Aug 2018
Dutch · born Jul 1964
Irena MelnikovaFind on LinkedIn ↗
director · since 14 Sept 2023
American · born Aug 1967
Nikola TrbovicFind on LinkedIn ↗
director · since 1 Jul 2023
German · born Mar 1982
Samantha TruexFind on LinkedIn ↗
director · since 15 Jun 2022
American · born Jul 1970

8 officers resigned over the company's life.

Opens a LinkedIn name search. We cannot confirm identities: check the profile mentions this company before relying on it, and if nothing comes up the person may simply not be on LinkedIn.

Control · PSC register

No active persons with significant control registered.

Holdings under 25% do not appear on this register; the cap table above (when filed) shows them.

Recent filings
SH1024 Aug 2026
capital variation of rights attached to shares
SH105 Aug 2026
capital variation of rights attached to shares
SH0130 Jun 2026
capital allotment sharesNew share allotment - a round may have closed; your % may have changed.
SH109 Feb 2026
capital variation of rights attached to shares
CS0111 Jan 2026
confirmation statement with updates
SH017 Jan 2026
capital allotment sharesNew share allotment - a round may have closed; your % may have changed.
That was the registers. Now the rest.

Tero's full due-diligence report reads the pitch deck, the market, the competition, the founders' track records and the digital footprint, cross-checked against 12+ official sources, with an adversarial pass before anything is stated.

Compiled from the Companies House public registers at the time shown; verify against the live register before acting. Register name matches are not identity confirmations. Tero is software. We are not a fund, we do not hold client money, and we do not provide investment advice or personal recommendations. Information, not tax or investment advice. Capital at risk.